Form 4 filings across 6 companies. Net figures count open-market buys and sales only. EDGAR profile ↗
Lifetime net: -$9.4M
Reported holding is the most recent post-transaction share count on a Table I row.
How quickly this filer reports. Section 16 allows two business days from the transaction.
All 11 filings we hold were filed within the two-business-day deadline.
Counted in business days from the transaction date, or the deemed execution date where the filing reports one, excluding weekends and federal holidays. How this is measured · All late filings
The 30 most recent Form 4 transactions.
| Aug 6 | ATTO | Attovia Therapeutics, Inc. | PBUY | 200,000 | $17.00 | $3.4M | +25.6% | Open the original filing on SEC.gov |
| Aug 6 | ATTO | Attovia Therapeutics, Inc. | CCONV | 782,854 | — | — | — | Open the original filing on SEC.gov |
| Jul 22 | ATRA | Atara Biotherapeutics,… | MEXER◆ | 55,387 | — | — | — | Open the original filing on SEC.gov |
| Jul 22 | ATRA | Atara Biotherapeutics,… | MEXER◆ | 38,735 | — | — | — | Open the original filing on SEC.gov |
| Jul 22 | ATRA | Atara Biotherapeutics,… | MEXER◆ | 101,089 | — | — | — | Open the original filing on SEC.gov |
| Jul 22 | ATRA | Atara Biotherapeutics,… | FTAX | 60 | — | — | <0.1% | Open the original filing on SEC.gov |
| Jul 22 | ATRA | Atara Biotherapeutics,… | MEXER | 195,211 | — | — | +44.2% | Open the original filing on SEC.gov |
| Jun 12 | FATE | Fate Therapeutics INC | AGRANT◆ | 87,900 | — | — | — | Open the original filing on SEC.gov |
| Apr 20 | FATE | Fate Therapeutics INC | JOTHER◆↺ | 266,280 | — | — | — | Open the original filing on SEC.gov |
| Apr 20 | FATE | Fate Therapeutics INC | JOTHER◆↺ | 266,280 | — | — | — | Open the original filing on SEC.gov |
| Apr 2 | ADCT | ADC Therapeutics SA | SSELL | 2.5M | $3.28 | $8.3M | -19.8% | Open the original filing on SEC.gov |
| Apr 2 | ADCT | ADC Therapeutics SA | SSELL | 2.6M | $3.28 | $8.6M | -17.2% | Open the original filing on SEC.gov |
| Apr 1 | ADCT | ADC Therapeutics SA | SSELL | 162,517 | $3.80 | $617.4K | -1.3% | Open the original filing on SEC.gov |
| Apr 1 | ADCT | ADC Therapeutics SA | SSELL | 169,265 | $3.80 | $643K | -1.1% | Open the original filing on SEC.gov |
| Mar 31 | ADCT | ADC Therapeutics SA | SSELL | 188,407 | $3.75 | $706.9K | -1.4% | Open the original filing on SEC.gov |
| Mar 31 | ADCT | ADC Therapeutics SA | SSELL | 196,229 | $3.75 | $736.3K | -1.3% | Open the original filing on SEC.gov |
| Oct 27, 2025 | ADCT | ADC Therapeutics SA | PDBUY◆ | 3.8M | $3.90 | $15M | — | Open the original filing on SEC.gov |
| Oct 27, 2025 | ADCT | ADC Therapeutics SA | PDBUY◆ | 3.8M | $3.90 | $15M | — | Open the original filing on SEC.gov |
| Aug 25, 2025 | STTK | Shattuck Labs, Inc. | AGRANT◆ | 4.1M | — | — | — | Open the original filing on SEC.gov |
| Aug 25, 2025 | STTK | Shattuck Labs, Inc. | AGRANT◆ | 4.1M | — | — | — | Open the original filing on SEC.gov |
| Aug 14, 2025 | IGMS | IGM Biosciences, Inc. | DTOISS◆ | 667,666 | — | — | — | Open the original filing on SEC.gov |
| Aug 14, 2025 | IGMS | IGM Biosciences, Inc. | DTOISS◆ | 7.2M | — | — | — | Open the original filing on SEC.gov |
| Aug 14, 2025 | IGMS | IGM Biosciences, Inc. | DTOISS | 3M | — | — | -100.0% | Open the original filing on SEC.gov |
| Jul 14, 2025 | STTK | Shattuck Labs, Inc. | AGRANT◆ | 33,150 | — | — | — | Open the original filing on SEC.gov |
| Jun 30, 2025 | IGMS | IGM Biosciences, Inc. | AGRANT | 828 | — | — | +<0.1% | Open the original filing on SEC.gov |
| Jun 11, 2025 | ADCT | ADC Therapeutics SA | PDBUY◆ | 12.5M | $3.43 | $42.8M | — | Open the original filing on SEC.gov |
| Jun 11, 2025 | ADCT | ADC Therapeutics SA | PDBUY◆ | 15.7M | $3.43 | $54M | — | Open the original filing on SEC.gov |
| May 29, 2025 | FATE | Fate Therapeutics INC | AGRANT◆ | 55,000 | — | — | — | Open the original filing on SEC.gov |